(Q37456631)

20 August 2017

1 reference

title

Binding of complement regulatory proteins to group A Streptococcus (English)

1 reference

Santiago Rodriguez de Córdoba

20 August 2017

author

series ordinal

3

1 reference

20 August 2017

Maria A Oliver

1

1 reference

20 August 2017

José M Rojo

series ordinal

2

1 reference

20 August 2017

Sebastián Alberti

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

20 August 2017

1 reference

20 August 2017

volume

26 Suppl 8

1 reference

20 August 2017

page(s)

I75-8

1 reference

Pathogenesis of group A streptococcal infections

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Streptococcal M protein: molecular design and biological behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Horizontal gene transfer in the evolution of group A streptococcal emm-like genes: gene mosaics and variation in Vir regulons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Modulation of the alternative complement pathways by beta 1 H globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38-kDa tryptic fragment containing the binding site for C3b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high-affinity group A Streptococcus binding site in FHL-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Role of the conserved C‐repeat region of the M protein of Streptococcus pyogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Integrins: bidirectional, allosteric signaling machines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Human C4-binding protein. I. Isolation and characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Spa contributes to the virulence of type 18 group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Engagement of CD46 and alpha5beta1 integrin by group A streptococci is required for efficient invasion of epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

The Scl1 protein of M6-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Protein F1 and Streptococcus pyogenes resistance to phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

inferred from DOI database lookup

7 January 2021

based on heuristic

Location of the complement factor H binding site on streptococcal M6 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.054

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.11.054

1 reference

20 August 2017

1 reference